The Tuscany Regional Healthcare Health Technology Assessments (HTA) body, responsible for evaluating healthcare technologies, has recently issued assessments for three medical devices in the areas of peripheral vascular, orthopedic, and dermatology. These assessments, published under regional decree 26990 on December 18, 2023, are part of the Health Technology Assessment body’s effort to provide full Health Technology Assessment reports, rapid Health Technology Assessment reports, and motivational forms for various medical technologies.
The evaluated technologies include:
ROTAREX-S Rotational Atherectomy System: Manufactured by Straub Medical, this device is used for the mechanical removal of calcific lesions of the leg arteries, specifically in smaller caliber vessels, in cases with calcific lesions and/or thromboembolic material.
TOUCH Uncemented Trapeziometacarpal Prosthesis: Produced by KeriMedical, this prosthesis is designed for patients with stages 2 and 3 osteoarthritis according to the Eaton classification.
Updated Health Technology Assessment Sheets on Dermatological and Medical Technologies
In addition to these, other dermatological technologies were assessed. These HTA Sheets, evaluating medical devices by the Commission for the Evaluation of Healthcare Technologies and Investments (CHTA), are now available for consultation and are published by regional decree.
Each HTA Sheet is organized chronologically and alphabetically, offering current sheets, previous versions if available, and the CHTA’s opinion (favorable or not favorable) regarding the purchase of the device. Starting January 2023, this opinion is reported in the “Extract of the CHTA Minutes”. As of September 6, 2023, the sheets also include an English language version.
The HTA body also assessed other medical devices in various fields, as evidenced by the extracts from the minutes of the CHTA meetings and the executive decrees publishing these assessments. Some of the other devices assessed include the Zephyr penile prosthesis, Derivo Peripher Embolisation Device, Emoled, Tack Endovascular System, and Vulnofast, among others.
Comprehensive Assessment of Diverse Medical Technologies Including Advanced Devices in Tuscany
These assessments cover a wide range of medical technologies, including devices like Acuson-Acunav, B-Lite, Cathglue, Diamondback 360, FlowTriever, Haart 200, Impella CP SmartAssist, Jetstream, Venus-P, Q-Fusion, Vest 2.0, Cardioform ASD, Vicryl Plus, Intraclude, Nimbus, Tactiflex, Triguard 3, GEASS grids, HAART300, Dynamesh, Optune, Organ Care System Heart, Ballast, Echo-Tip, Farawave, Lightning, WavelinQ, Angiovac Disposable kit, AtriClip Flex ACH2 Atricure, Braxon Fast, Cardioform ASD, ER-REBOA, Motiva Flora, Figulla Flex II UNI Occluder, TYRX, Bundle, Figulla Flex II PFO Occluder, Hanarostent, Histolock, Hy Tissue, M.Blue Plus, Megasystem Upper Limb, Micra AV, Pascal Mitral Ace, Pascal Tricuspid Ace, Reemex, Relief, Serasynth, Sinovial HL, and Tessys.
These rapid HTA reports reflect the Tuscany Regional Healthcare’s commitment to evaluating a diverse array of medical devices, ensuring that healthcare providers in the region have access to the latest and most effective medical technologies. The thoroughness of these assessments demonstrates the region’s dedication to advancing healthcare quality and innovation.
Resource: Med Tech Reimbursement Consulting, January 18, 2024
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
